Alberta Investment Management Corp Has $4.33 Million Stake in Agilent Technologies, Inc. $A

Alberta Investment Management Corp raised its stake in Agilent Technologies, Inc. (NYSE:A) by 21.5% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 36,700 shares of the medical research company’s stock after acquiring an additional 6,500 shares during the period. Alberta Investment Management Corp’s holdings in Agilent Technologies were worth $4,331,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of A. Citizens Financial Group Inc. RI grew its stake in Agilent Technologies by 25.3% in the 2nd quarter. Citizens Financial Group Inc. RI now owns 2,493 shares of the medical research company’s stock valued at $294,000 after purchasing an additional 503 shares during the period. Intech Investment Management LLC grew its holdings in shares of Agilent Technologies by 77.7% during the second quarter. Intech Investment Management LLC now owns 5,006 shares of the medical research company’s stock worth $591,000 after purchasing an additional 2,189 shares in the last quarter. LGT Capital Partners LTD. lifted its holdings in shares of Agilent Technologies by 4.6% during the 2nd quarter. LGT Capital Partners LTD. now owns 803,898 shares of the medical research company’s stock worth $94,868,000 after acquiring an additional 35,646 shares during the last quarter. Creative Planning raised its stake in shares of Agilent Technologies by 112.1% during the second quarter. Creative Planning now owns 91,846 shares of the medical research company’s stock worth $10,839,000 after acquiring an additional 48,533 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in Agilent Technologies by 7.2% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 69,923 shares of the medical research company’s stock worth $8,252,000 after purchasing an additional 4,681 shares during the period. 87.41% of the stock is owned by institutional investors and hedge funds.

Agilent Technologies Stock Up 0.0%

Shares of A opened at $146.90 on Monday. The company has a market capitalization of $41.65 billion, a P/E ratio of 34.48, a PEG ratio of 4.67 and a beta of 1.29. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $153.84. The business’s 50 day simple moving average is $137.63 and its 200-day simple moving average is $124.00. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting analysts’ consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter in the previous year, the firm earned $1.32 earnings per share. The business’s revenue was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. As a group, sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th were issued a $0.248 dividend. This represents a $0.99 annualized dividend and a yield of 0.7%. The ex-dividend date was Tuesday, September 30th. Agilent Technologies’s dividend payout ratio is currently 23.24%.

Insiders Place Their Bets

In related news, CEO Padraig Mcdonnell sold 12,490 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the transaction, the chief executive officer owned 33,448 shares of the company’s stock, valued at $5,017,200. This trade represents a 27.19% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.26% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Evercore ISI increased their price target on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 7th. Weiss Ratings reiterated a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday, October 8th. UBS Group upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and upped their price target for the stock from $130.00 to $170.00 in a research report on Wednesday, October 8th. Rothschild & Co Redburn began coverage on Agilent Technologies in a report on Wednesday, October 8th. They issued a “buy” rating and a $165.00 price target on the stock. Finally, Wells Fargo & Company boosted their target price on Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research report on Monday, September 15th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $149.62.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.